Siemens Healthineers AG header image

Siemens Healthineers AG

SHL

Equity

ISIN DE000SHL1006 / Valor 40652181

Xetra (2026-02-23)
EUR 41.55-1.89%

Siemens Healthineers AG
UMushroom community rating:

star star star star star
4.75 6 votes No rating yet
NegativeNeutralPositive

About company

Siemens Healthineers AG is a global medical-technology company headquartered in Erlangen, Germany, that develops, manufactures and sells diagnostic imaging systems (CT, MRI, X‑ray, ultrasound), laboratory diagnostics and molecular testing platforms, and image‑guided and radiotherapy systems for hospitals, clinical laboratories and outpatient providers. It generates revenue from capital equipment sales, consumables and reagents, long‑term service and maintenance contracts, and growing software and digital‑services offerings — including AI‑enabled diagnostic and workflow tools and remote monitoring/managed‑services arrangements. Formed as a separately listed entity following a carve‑out from Siemens AG, the company operates across many countries with a broad installed base and competing on technology, service networks and recurring revenues rather than low‑margin commodity products.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-25.5%1Y
-16.1%3Y
-10.5%5Y

Performance

25.0%1Y
23.3%3Y
25.2%5Y

Volatility

Market cap

54666 M

Market cap (USD)

Daily traded volume (Shares)

1,199,885

Daily traded volume (Shares)

1 day high/low

52.22 / 51.78

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.75

6 votes
Performance:
starstarstarstarstar
4.63
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
4.63
Nature:
starstarstarstarstar
3.57
Nathalie Kuba
Switzerland, 18 Apr 2025
star star star star star
Sehr stabil
Lea Katunaric
Switzerland, 08 Mar 2023
star star star star star
Laura Bischofberger
Switzerland, 08 Mar 2023
star star star star star

EQUITIES OF THE SAME SECTOR

Gyre Therapeutics Inc
Gyre Therapeutics Inc Gyre Therapeutics Inc Valor: 130270397
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 8.15
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.78%USD 24.11
ModivCare Inc
ModivCare Inc ModivCare Inc Valor: 59168951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-25.23%USD 0.43
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.43%USD 27.55
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.40%USD 72.65
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.54%USD 5.57
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.10%USD 3.35
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%USD 67.91
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.41%USD 2.16
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%USD 183.65